Eden Research (LON:EDEN) Shares Down 4.7% – Time to Sell?

Eden Research plc (LON:EDEN)’s share price traded down 4.7% during trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). 291,737 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The firm’s 50-day simple moving average is GBX 3.87 and its 200 day simple moving average is GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92.

Insiders Place Their Bets

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.